Julio Hernan Cuervo

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 2

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 10.0

ph-index = 6

Forward Citations = 79(Granted Patents)

Location History:

Cambridge, MA (US) (2001 - 2003)
Arlington, MA (US) (2001 - 2020)

Company Filing History:

Sunesis Pharmaceuticals, Inc.

Bristol-myers Squibb Compnay

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12473304 - Heterocyclic PAD4 inhibitors (2025-11-18),

2. 10577374 - Bruton's tyrosine kinase inhibitors (2020-03-03),

3. 9790229 - Bruton's tyrosine kinase inhibitors (2017-10-17),

4. 9273028 - Heterocyclic tyrosine kinase inhibitors (2016-03-01),

5. 9249146 - Bruton'S tyrosine kinase inhibitors (2016-02-02),

6. 8785440 - Bruton's tyrosine kinase inhibitors (2014-07-22),

7. 8618042 - Binding molecules and methods of use thereof (2013-12-31),

8. 6875743 - Cell adhesion inhibitors (2005-04-05),

9. 6630512 - Cell adhesion inhibitors (2003-10-07),

10. 6596687 - Cell adhesion inhibitors (2003-07-22),

11. 6376538 - Cell adhesion inhibitors (2002-04-23),

12. 6248713 - Cell adhesion inhibitors (2001-06-19),

13. 6239108 - Cell adhesion inhibitors (2001-05-29),

Title: Innovations of Julio Hernan Cuervo

Introduction

Julio Hernan Cuervo is a prominent inventor based in Arlington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of inhibitors for Bruton's tyrosine kinase (Btk). With a total of 12 patents to his name, Cuervo's work has had a substantial impact on therapeutic approaches for various diseases.

Latest Patents

Cuervo's latest patents focus on Bruton's tyrosine kinase inhibitors. The present invention provides compounds useful as inhibitors of Btk, compositions thereof, and methods of using the same. This innovative approach aims to enhance treatment options for conditions related to Btk activity.

Career Highlights

Throughout his career, Julio Hernan Cuervo has worked with notable companies such as Biogen, Incorporated and Sunesis Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and biotechnology.

Collaborations

Cuervo has collaborated with esteemed colleagues, including Daniel M. Scott and Steven P. Adams. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Julio Hernan Cuervo's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.